CD300A and acute lymphoblastic leukemia: There are only few evidences that CD300A was found to be significantly overexpressed in hematological malignancies, such as acute lymphoblastic leukemia (ALL),26, 27 AML,28 and diffuse large B‐cell lymphoma (DLBCL).29